Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,737,175
+$1,034,786 QoQ
Shares Held
30,747
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.79%
of 13F equity value
Holder Rank
#1,047
of 4,153 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wellington Shields & Co., LLC holds $37,282,872 across 9 Drug Manufacturers - General names. ABBV ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,972 | $15,559,007 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
30,747 | $7,737,175 | |
| 3 | JNJ |
Johnson & Johnson
|
17,288 | $4,390,633 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,666 | $2,912,581 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
39,424 | $2,271,610 | |
| 6 | PFE |
Pfizer Inc
|
74,795 | $1,801,063 | |
| 7 | AMGN |
Amgen Inc
|
4,929 | $1,784,889 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,963 | $753,365 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,737,175 | 30,747 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,702,389 | 30,817 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,041,376 | 30,817 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,817,000 | 29,442 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,520,710 | 29,742 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $6,381,350 | 30,457 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,318,916 | 29,932 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,852,714 | 29,637 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,077,678 | 29,604 | Shares | Sole | 2024-08-07 | |
| 2023-09-30 | $4,555,571 | 30,562 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,684,057 | 27,344 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,527,748 | 34,685 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,384,360 | 33,317 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,378,332 | 32,623 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,137,752 | 33,545 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,442,519 | 33,573 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,407,811 | 32,554 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,447,201 | 31,957 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,622,727 | 32,162 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,304,064 | 30,531 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,213,535 | 29,991 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,655,028 | 30,312 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,985,751 | 30,411 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,931,492 | 25,351 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||